Search Results
You are looking at 1 - 2 of 2 items for
- Author: S. J. Dunmore x
- Refine by access: All content x
Search for other papers by S. J. Dunmore in
Google Scholar
PubMed
Search for other papers by M. A. Cawthorne in
Google Scholar
PubMed
Search for other papers by D. C. J. Hislop in
Google Scholar
PubMed
Search for other papers by J. L. Morton in
Google Scholar
PubMed
Search for other papers by A. Beloff-Chain in
Google Scholar
PubMed
ABSTRACT
The neurointermediate pituitary peptide β-cell tropin (BCT) has potent insulin-releasing and lipogenic properties and is elevated in obesity and type-2 diabetes. The effects of BCT and glucose on the release of insulin and amylin from the perfused pancreas of obese 'fatty' (fa/fa) rats and lean (Fa/?) controls were measured. Pancreata were perfused, sequentially, with buffer containing: 5·6 mmol glucose/l (basal); basal glucose±0·5 nmol BCT/l; 16·7 mmol glucose/l (high). Insulin and amylin release during basal glucose treatment was eight to nine times greater from pancreata from fatty than from lean rats. BCT induced a fivefold greater monophasic insulin and amylin release from fatty compared with lean pancreata. When not preceded by BCT there was a twofold greater high glucose-induced amylin release from fatty pancreata but no difference in insulin secretion. When preceded by BCT stimulation, high glucose induced twofold greater insulin and fourfold larger amylin release from fatty compared with lean pancreata. Molar secretion ratios of insulin: amylin varied between 30:1 and 50:1. In view of the elevated levels of BCT found in the fatty rat and in the light of the above findings, it is concluded that the peptide may have a role in the development of hyperinsulinaemia, hyperamylinaemia and insulin resistance in this animal model of obesity and diabetes.
Journal of Endocrinology (1993) 137, 375–381
Search for other papers by A. Salvatoni in
Google Scholar
PubMed
Search for other papers by S. J. Dunmore in
Google Scholar
PubMed
Search for other papers by J. L. Morton in
Google Scholar
PubMed
Search for other papers by A. T. Etienne in
Google Scholar
PubMed
Search for other papers by A. Beloff-Chain in
Google Scholar
PubMed
Search for other papers by R. R. Abraham in
Google Scholar
PubMed
ABSTRACT
It has been demonstrated that the insulin secretagogue β-cell-trophin, ACTH(22–39), is present in human plasma. The hormone, separated from plasma by affinity chromatography on a corticotrophin-like intermediate-lobe peptide antibody column, behaves similarly to synthetic β-cell-trophin on a gel filtration column and on reverse-phase high-performance liquid chromatography. Sufficient amounts of the hormone were isolated from the plasma of two patients with Nelson's syndrome to demonstrate its biological activity on the perfused rat pancreas.
J. Endocr. (1986) 110, 303–307
